MedTrace Logo

Usability of the Foresee Home in Intermediate Age Related Macular Degeneration (AMD) Patients

NCT00748384 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2013-05-15

No results posted yet for this study

Summary

The study purpose is to demonstrate that the target population can receive a packed FORESEE HOME unpack it, install and operate it to an extent that the FORESEE HOME can monitor them for changes in the visual field with good specificity. And evaluate the device usage on a small scale, at the subjects' homes before a commercial use.

Conditions

  • Age Related Macular Degeneration

Sponsors & Collaborators

  • Notal Vision Ltd.

    lead INDUSTRY

Principal Investigators

  • Haya Morori Katz, M.D. · Kaplan Medical Center

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-02-28
Primary Completion
2013-03-31
Completion
2013-05-31

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00748384 on ClinicalTrials.gov